P&G sues J&J over tooth-whitening patent
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble alleges Johnson & Johnson and McNeil-PPC violated its patents for the active ingredient and delivery systems used in its tooth-whitening strips, according to P&G's May 2 release. The lawsuit filed in the U.S. District Court for the Western District of Wisconsin seeks to stop J&J and McNeil from making, selling and importing any products that infringe on P&G's patents. This ostensibly includes stopping J&J and McNeil from making and selling its Listerine Whitening Quick Dissolving Strips. P&G argues it invested heavily in research and development for its Crest Whitestrips and that it must protect its technology and intellectual property...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.